Always on time, friendly staff, and Dr. Callahan answers all questions clearly. The office is very clean, and several of my family members also go here. An all-around great practice.
Bernadette Amos-Watts
Restasis is an FDA-approved prescription eye drop that treats chronic dry eye at its source rather than simply masking discomfort. It contains cyclosporine, an immunomodulating agent, meaning it works with your immune system to reduce the ocular surface inflammation that prevents your tear glands from functioning properly.
Artificial tears and lubricating drops provide temporary relief by coating the eye surface, but they do not address the underlying inflammation that causes chronic dry eye. Restasis works over time to reduce that inflammation, helping your eyes restore their natural ability to produce tears. It comes in preservative-free, single-use vials, making it a gentle choice for patients with sensitive eyes.
Restasis is approved for adults with chronic dry eye associated with inflammation and reduced tear production. It is particularly well-suited for patients whose symptoms persist even with regular use of lubricating drops, and for those with inflammatory conditions like Sjogren's syndrome that affect tear gland function. Our eye doctors will assess whether inflammation is a significant factor in your dry eye before recommending Restasis.
Restasis requires a comprehensive eye examination before it can be prescribed. During that visit, our eye doctors evaluate your symptoms, measure tear production, and examine the ocular surface to confirm that inflammation is contributing to your dry eye. This careful process ensures the right treatment is matched to your specific condition. A generic version containing the same active ingredient, cyclosporine ophthalmic emulsion, is also available and may be a more cost-accessible option.
Restasis interrupts the cycle of inflammation that keeps chronic dry eye from improving on its own. Understanding how it works helps set realistic expectations about when and how you will start to feel better.
In chronic dry eye, reduced tear production leads to eye surface irritation. That irritation triggers an immune response, which causes inflammation in the tear glands, which in turn reduces tear production further. Cyclosporine in Restasis blocks specific immune cells that drive this process, allowing the tear glands to gradually recover their normal function.
Restasis does not provide immediate comfort. Most patients begin to notice gradual symptom improvement within four to six weeks, and full benefits typically develop after three to six months of consistent use. This timeline reflects how long it takes for inflammation to subside and for tear gland activity to improve. Patience and consistency are both essential parts of the treatment.
Restasis works best when paired with supportive habits and therapies. Our eye doctors may also recommend over-the-counter lubricating drops for immediate comfort between doses, warm-compress therapy to support healthy oil gland function in the eyelids, and punctal plugs (tiny devices placed in the tear drainage openings to help retain moisture on the eye surface). In some cases, Xiidra, another prescription dry eye drop that targets a different inflammatory pathway, may be considered alongside or instead of Restasis depending on your individual response and needs.
Getting the most from Restasis depends on proper application technique and a consistent schedule. Using it correctly each day helps the medication absorb well and reduces the chance of side effects or contamination.
Start by washing your hands thoroughly. Gently shake the single-use vial, then tilt your head back and look upward. Use a clean finger to gently pull your lower eyelid downward, creating a small pocket. Hold the vial above your eye without letting the tip touch your eye, eyelid, or skin, and squeeze one drop into the pocket. Gently close your eyes for one to two minutes to allow the drop to absorb fully.
The standard dosing is one drop in each affected eye twice daily, spaced approximately twelve hours apart. Using Restasis at consistent times each day, such as morning and evening, makes it easier to maintain a steady routine. If you miss a dose, apply it as soon as you remember unless it is nearly time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Do not double up.
Keep unopened Restasis vials stored at room temperature, away from heat and direct sunlight, and do not freeze them. Each vial is designed for single use only and should be discarded after applying the drop to both eyes, even if liquid remains. If you wear contact lenses, remove them before applying Restasis and wait at least fifteen minutes before putting them back in.
Restasis is generally well tolerated, and most side effects are mild and temporary. Knowing what to watch for helps you feel confident during treatment and know when to reach out to our eye doctors.
The most frequently reported side effect is a temporary burning or stinging sensation immediately after applying the drop. This is common during the early weeks of treatment and tends to lessen as your eyes adjust. Other possible side effects include temporary blurred vision, mild redness, discharge, or the sensation of something in the eye. These typically improve over time and rarely require stopping treatment.
Reach out to our team promptly if you experience severe eye pain, sudden changes in vision, significant swelling of the eye or eyelid, or any signs of eye infection such as increased redness, discharge, or light sensitivity. Allergic reactions to Restasis are uncommon but require immediate care.
Restasis should not be used by anyone with an active eye infection. Patients with a history of herpes simplex keratitis, a viral infection of the cornea, should use it only under close medical supervision. If you are pregnant or nursing, discuss the risks and benefits with your eye doctor, as safety in those situations has not been fully established. Anyone with a known allergy to cyclosporine or other ingredients in Restasis should not use it.
These answers address the practical questions our patients most often have about using Restasis day to day, managing expectations, and coordinating it with other parts of their care.
Progress with Restasis tends to be gradual rather than dramatic. Signs that it is working include slowly reducing reliance on artificial tears, less grittiness or burning during sustained visual tasks, and improved overall comfort throughout the day. During follow-up visits, our eye doctors may use objective tests to measure changes in tear production, which can confirm improvement even before symptoms fully resolve. Tracking your daily comfort on a simple scale can also help you notice changes over time.
Yes, and doing so is often encouraged, especially in the early months before Restasis reaches its full effect. If you use preserved artificial tears, wait at least fifteen minutes after applying Restasis before using them to avoid diluting the medication. Preservative-free lubricating drops are a particularly good option to use alongside Restasis, as they cause less surface irritation with frequent use.
Both are prescription treatments for chronic dry eye, but they work through different mechanisms and may suit different patients. Restasis uses cyclosporine to gradually reduce tear gland inflammation over several months. Xiidra uses lifitegrast to block a specific protein involved in a different part of the inflammatory process and may offer faster symptom relief for some patients. Our eye doctors will help you weigh the options based on your symptom pattern, health history, and how your eyes respond to treatment.
Yes. Many patients benefit from a layered approach that combines Restasis with supportive therapies. Warm-compress therapy can help keep the meibomian glands (the oil-producing glands along the eyelid margin) functioning properly, which improves tear stability. Punctal plugs can help retain natural tears and artificial tears on the eye surface longer. Our eye doctors will recommend the combination that makes the most sense for your specific dry eye type.
Coverage for Restasis varies by insurance plan and formulary. A generic version, cyclosporine ophthalmic emulsion, contains the same active ingredient and may be available at a lower cost. We recommend checking with your insurance provider or pharmacy before your first fill. Our team can also help guide you toward financing or cost-management options that may apply to your situation.
When starting Restasis, follow-up visits every three to six months are typically recommended to monitor your progress, check tear production, and confirm the treatment is well tolerated. Once your condition is stable and well-managed, visit frequency may decrease. Regular check-ins remain important because dry eye can change over time with age, medication changes, or shifts in environment, and your treatment plan may need to be adjusted accordingly.
Our team at NewView Eye Center is committed to helping each patient find lasting relief from chronic dry eye through careful evaluation, personalized treatment plans, and attentive ongoing care. We combine experienced eye doctors with a full range of proven therapies to meet your eyes where they are and guide them toward better health. If you are living with persistent dry eye symptoms, we encourage you to schedule a comprehensive eye exam with us so we can determine the right path forward for you.
Find more information about our doctors, services, and technology that keep your eyes healthy and your vision at its best.